| Literature DB >> 31669052 |
Akira Tsujimura1, Ippei Hiramatsu2, Yuki Nagashima3, Keisuke Ishikawa3, Yuka Uesaka4, Taiji Nozaki4, Tatsuya Ogishima4, Masato Shirai4, Kazutaka Terai5, Kazuhiro Kobayashi6, Shigeo Horie7.
Abstract
INTRODUCTION: As a continuous decline in semen concentration has been reported, the concept of male infertility has gained increased attention. Although several surveys of semen quality have been conducted in young men in general, no study has reported only on newlywed men. AIM: The aim of this study was to evaluate semen quality and assess its characteristics in newlywed men.Entities:
Keywords: Age; Erectile Dysfunction; Luteinizing Hormone; Newlywed Men; Semen Quality
Year: 2019 PMID: 31669052 PMCID: PMC7042159 DOI: 10.1016/j.esxm.2019.09.005
Source DB: PubMed Journal: Sex Med ISSN: 2050-1161 Impact factor: 2.491
Clinical characteristics of 564 men just before wedding or newly wed
| Case | 564 | |
| Unmarried, N (%) | 271 (48) | |
| Married, N (%) | 293 (52) | |
| (Duration after marriage [months] 8.6 ± 3.3) | ||
| Age, years | 35.5 ± 6.7 | (21−66) |
| BMI, kg/m2 | 22.7 ± 3.0 | (12.1−37.6) |
| Smoking, N (%) | 86 (15.2) | |
| Testicular volume, mL | ||
| Right | 20.6 ± 3.8 | (2−30) |
| Left | 19.6 ± 4.2 | (1−30) |
| Total cholesterol, mg/dL | 196.0 ± 32.9 | (99−305) |
| HDL cholesterol, mg/dL | 60.2 ± 13.3 | (30−115) |
| LDL cholesterol, mg/dL | 120.2 ± 30.7 | (45−226) |
| Triglyceride, mg/dL | 91.8 ± 61.2 | (19−658) |
| BUN, mg/dL | 12.9 ± 2.9 | (6.6−21.7) |
| Creatinine, mg/dL | 0.8 ± 0.1 | (0.6−1.2) |
| Urinary acid, mg/dL | 6.0 ± 1.2 | (0.7−10.3) |
| AST, U/L | 22.8 ± 12.7 | (12−233) |
| ALT. U/L | 26.0 ± 20.5 | (7−178) |
| γ-GTP, U/L | 35.8 ± 34.5 | (9−295) |
| ALP, U/L | 195.0 ± 48.9 | (60−403) |
| Total bilirubin, mg/dL | 0.9 ± 0.3 | (0.2−2.9) |
| Total protein, g/dL | 7.4 ± 0.4 | (6.1−8.5) |
| Albumin, g/dL | 4.8 ± 0.3 | (3.9−5.6) |
| A/G | 1.8 ± 0.2 | (1.2−2.8) |
| Na, mEq/L | 142.2 ± 1.5 | (139−148) |
| K, mEq/L | 3.9 ± 0.3 | (3.0−5.7) |
| CL, mEq/L | 103.3 ± 1.8 | (98−109) |
| FBS, mg/dL | 87.0 ± 9.7 | (65−157) |
| HbA1c, (%) | 5.3 ± 0.3 | (4.5−7.3) |
| LH, mIU/mL | 3.3 ± 1.8 | (0.1−16.8) |
| FSH, mIU/mL | 4.3 ± 3.8 | (1.1−60.1) |
| Testosterone, ng/mL | 5.5 ± 1.9 | (1.1−14.7) |
| Estradiol, pg/mL | 25.0 ± 9.6 | (10−86) |
| Prolactin, ng/mL | 24.5 ± 156.3 | (4.1−3,605.0) |
| DHEA-S, μg/dL | 300.8 ± 105.6 | (65−777) |
| IGF-1, ng/mL | 152.2 ± 38.9 | (59−389) |
| Cortisol, μg/dL | 9.7 ± 4.6 | (0.2−35.4) |
| IPSS | 3.4 ± 3.7 | (0−24) |
| BDI | 5.4 ± 5.4 | (0−42 |
| SHIM | 18.9 ± 5.3 | (1−25) |
| EHS | 3.5 ± 0.7 | (1−4) |
| AMS | 24.9 ± 7.6 | (17−61) |
A/G = albumin to globulin ratio; ALP = alkaline phosphatase; ALT = alanine aminotransferase; AMS = Aging Males Symptom; AST = aspartate aminotransferase; BDI = Beck Depression Inventory; BMI = body mass index; BUN = blood urea nitrogen; CL = chloride; DHEA-S = dehydroepiandrosterone sulfate; EHS = Erection Hardness Score; FBS = fasting blood sugar; FSH = follicle-stimulating hormone; γ-GTP = gamma-glutamyltransferase; HbA1c = hemoglobin A1c; HDL = high-density lipoprotein; IGF-1 = insulin-like growth factor-1; IPSS = International Prostate Symptom Score; K = potassium; LDL = low-density lipoprotein; LH = luteinizing hormone; Na = sodium; SHIM = Sexual Health Inventory for Men.
Rates of semen volume, sperm concentration and sperm motility exceeding the lower limit of normal
| Semen volume <1.5 mL | 62 (11.0%) |
| Sperm concentration <15 × 106/mL | 52 (9.2%) |
| ≥5 × 106/mL | 31 (5.4%) |
| <5 × 106/mL | 11 (2.0%) |
| Azoospermia | 10 (1.8%) |
| Sperm motility <40% | 60 (10.6%) |
Semen quality the normal group and poor group
| Normal | Poor | ||
|---|---|---|---|
| (N = 421; 74.6%) | (N = 143; 25.4%) | ||
| Age, years | 34.3 ± 5.9 | 38.8 ± 7.7 | < .001 |
| BMI, kg/m2 | 22.6 ± 2.9 | 23.2 ± 3.2 | .013 |
| Smoking, N (%) | 63 (15.0) | 23 (16.1) | .788 |
| Testicular volume, mL | |||
| Right | 20.9 ± 3.5 | 19.7 ± 4.6 | .015 |
| Left | 20.0 ± 3.9 | 18.6 ± 5.1 | .003 |
| Total cholesterol, mg/dL | 194.4 ± 32.9 | 200.8 ± 32.3 | .128 |
| HDL cholesterol, mg/dL | 60.4 ± 12.8 | 59.5 ± 14.9 | .203 |
| LDL cholesterol, mg/dL | 119.0 ± 30.6 | 123.9 ± 30.9 | .133 |
| Triglyceride, mg/dL | 88.6 ± 56.0 | 101.6 ± 74.4 | .051 |
| BUN, mg/dL | 12.9 ± 2.8 | 12.9 ± 3.0 | .708 |
| Creatinine, mg/dL | 0.8 ± 0.1 | 0.8 ± 0.1 | .208 |
| Urinary acid, mg/dL | 6.0 ± 1.2 | 5.9 ± 1.2 | .146 |
| AST, U/L | 22.7 ± 13.8 | 23.1 ± 8.7 | .098 |
| ALT, U/L | 25.3 ± 20.1 | 28.2 ± 21.7 | .050 |
| γ-GTP, U/L | 33.6 ± 31.6 | 42.7 ± 41.5 | < .001 |
| ALP, U/L | 195.0 ± 48.4 | 195.0 ± 50.5 | .700 |
| Total bilirubin, mg/dL | 0.9 ± 0.3 | 0.9 ± 0.4 | .687 |
| Total protein, g/dL | 7.4 ± 0.4 | 7.4 ± 0.4 | .450 |
| Albumin, g/dL | 4.8 ± 0.3 | 4.8 ± 0.3 | .132 |
| A/G | 1.8 ± 0.3 | 1.8 ± 0.2 | .943 |
| Na, mEq/L | 142.2 ± 1.5 | 142.3 ± 1.6 | .553 |
| K, mEq/L | 3.9 ± 0.3 | 3.9 ± 0.3 | .159 |
| CL, mEq/L | 103.3 ± 1.8 | 103.5 ± 1.9 | .161 |
| FBS, mg/dL | 86.0 ± 8.1 | 90.0 ± 13.1 | .002 |
| HbA1c, % | 5.3 ± 0.3 | 5.3 ± 0.3 | .132 |
| LH, mIU/mL | 3.2 ± 1.5 | 3.6 ± 2.5 | .088 |
| FSH, mIU/mL | 3.8 ± 1.9 | 5.8 ± 6.8 | .001 |
| Testosterone, ng/mL | 5.6 ± 1.9 | 5.4 ± 1.9 | .231 |
| Estradiol, pg/mL | 24.8 ± 9.1 | 25.5 ± 10.9 | .976 |
| Prolactin, ng/mL | 26.8 ± 179.5 | 17.2 ± 9.2 | .080 |
| DHEA-S, μg/dL | 305.3 ± 106.5 | 286.8 ± 101.9 | .245 |
| IGF-1, ng/mL | 153.3 ± 38.9 | 148.7 ± 38.5 | .125 |
| Cortisol, μg/dL | 9.6 ± 4.4 | 9.8 ± 5.5 | .653 |
| IPSS | 3.2 ± 3.5 | 4.1 ± 4.2 | .014 |
| SHIM | 19.4 ± 5.1 | 17.5 ± 5.8 | < .001 |
| EHS | 3.5 ± 0.7 | 3.3 ± 0.7 | < .001 |
| AMS | 24.3 ± 7.2 | 26.7 ± 8.5 | < .001 |
A/G = albumin to globulin ratio; ALP = alkaline phosphatase; ALT = alanine aminotransferase; AMS = Aging Males Symptom; AST = aspartate aminotransferase; BDI = Beck Depression Inventory; BMI = body mass index; BUN = blood urea nitrogen; CL = chloride; DHEA-S = dehydroepiandrosterone sulfate; EHS = Erection Hardness Score; FBS = fasting blood sugar; FSH = follicle-stimulating hormone; γ-GTP = gamma-glutamyltransferase; HbA1c = hemoglobin A1c; HDL = high-density lipoprotein; IGF-1 = insulin-like growth factor-1; IPSS = International Prostate Symptom Score; K = potassium; LDL = low-density lipoprotein; LH = luteinizing hormone; Na = sodium; SHIM = Sexual Health Inventory for Men.
Independent factors influencing semen analysis in the poor group
| Variable | Category | N | Poor case | Multivariate analysis model 1 | Multivariate analysis model 2 | ||||
|---|---|---|---|---|---|---|---|---|---|
| Odds ratio | [Variable P] | Odds ratio | [Variable P] | ||||||
| Point estimation | 95% CI | Category P | Point estimation | 95% CI | Category P | ||||
| Age | 21−<30 | 87 | 9 (10.3%) | Reference | - | [0.149] | Reference | - | [0.009] |
| 30−<34 | 130 | 23 (17.7%) | 1.903 | (0.791, 4.578) | 0.151 | 1.794 | (0.775, 4.150) | 0.172 | |
| 34−<39 | 134 | 33 (24.6%) | 2.170 | (0.924, 5.099) | 0.075 | 2.563 | (1.134, 5.791) | 0.024 | |
| 39−65 | 129 | 43 (33.3%) | 2.778 | (1.158, 6.665) | 0.022 | 3.545 | (1.591, 7.900) | 0.002 | |
| Rt. testicular | 2−<18 | 86 | 29 (33.7%) | 0.661 | (0.186, 2.355) | 0.523 | |||
| Volume | 18−<20 | 44 | 11 (25.0%) | 0.437 | (0.132, 1.449) | 0.176 | |||
| 20−<24 | 214 | 39 (18.2%) | 0.457 | (0.220, 0.953) | 0.037 | ||||
| 24−30 | 136 | 29 (21.3%) | Reference | - | [0.168] | ||||
| Lt. testicular | 2−<18 | 117 | 37 (31.6%) | 2.208 | (0.718, 6.783) | 0.167 | |||
| Volume | 18−<20 | 77 | 17 (22.1%) | 2.408 | (0.918, 6.318) | 0.074 | |||
| 20−<22 | 90 | 21 (23.3%) | 2.133 | (0.971, 4.684) | 0.059 | ||||
| 22−30 | 196 | 33 (16.8%) | Reference | - | [0.196] | ||||
| SHIM | 1−<18 | 119 | 35 (29.4%) | 0.886 | (0.424, 1.850) | 0.747 | |||
| 18−<21 | 114 | 30 (26.3%) | 1.060 | (0.534, 2.106) | 0.867 | ||||
| 21−<23 | 80 | 13 (16.3%) | 0.619 | (0.277, 1.382) | 0.242 | ||||
| 23−25 | 167 | 30 (18.0%) | Reference | - | [0.590] | ||||
| EHS | 0−3 | 206 | 61 (29.6%) | 1.829 | (1.031, 3.245) | 0.039 | 1.844 | (1.167, 2.913) | 0.009 |
| 4 | 274 | 47 (17.2%) | Reference | - | - | Reference | - | - | |
| γ-GTP | 9−<18.5 | 120 | 18 (15.0%) | Reference | - | [0.469] | |||
| 18.5−<24 | 113 | 21 (18.6%) | 1.198 | (0.566, 2.534) | 0.636 | ||||
| 24−<39 | 126 | 36 (28.6%) | 1.649 | (0.819, 3.322) | 0.161 | ||||
| 39−295 | 121 | 33 (27.3%) | 1.586 | (0.768, 3.275) | 0.213 | ||||
| Creatine | 0.55−<0.77 | 117 | 27 (23.1%) | Reference | - | [0.148] | |||
| 0.77−<0.83 | 112 | 18 (16.1%) | 0.885 | (0.426, 1.841) | 0.744 | ||||
| 0.83−<0.90 | 124 | 24 (19.4%) | 0.968 | (0.485, 1.931) | 0.925 | ||||
| 0.90−1.20 | 127 | 39 (30.7%) | 1.733 | (0.913, 3.289) | 0.093 | ||||
| FBS | 65−<81 | 109 | 17 (15.6%) | 0.935 | (0.419, 2.086) | 0.870 | |||
| 81−<85 | 103 | 18 (17.5%) | Reference | - | [0.261] | ||||
| 85−<90.5 | 148 | 35 (23.6%) | 1.468 | (0.734, 2.936) | 0.278 | ||||
| 90.5−157 | 120 | 38 (31.7%) | 1.770 | (0.861, 3.636) | 0.120 | ||||
| LH | 0.92−<2.29 | 118 | 30 (25.4%) | 2.634 | (1.230, 5.639) | 0.013 | 2.604 | (1.263, 5.366) | 0.010 |
| 2.29−<3.10 | 119 | 13 (10.9%) | Reference | - | [0.034] | Reference | - | [0.002] | |
| 3.10−<4.015 | 123 | 26 (21.1%) | 2.210 | (1.023, 4.773) | 0.044 | 2.267 | (1.088, 4.727) | 0.029 | |
| 4.015−16.79 | 120 | 39 (32.5%) | 2.958 | (1.351, 6.477) | 0.007 | 3.941 | (1.937, 8.019) | <0.001 | |
| FSH | 1.10−<2.59 | 119 | 23 (19.3%) | 1.858 | (0.862, 4.005) | 0.114 | |||
| 2.59−<3.565 | 121 | 18 (14.9%) | Reference | - | [0.192] | ||||
| 3.565−<4.99 | 120 | 25 (20.8%) | 1.688 | (0.794, 3.585) | 0.173 | ||||
| 4.99−60.11 | 120 | 42 (35.0%) | 2.255 | (1.042, 4.880) | 0.039 | ||||
EHS = Erection Hardness Score; FBS = fasting blood sugar; FSH = follicle-stimulating hormone; γ-GTP = gamma-glutamyltransferase; LH = luteinizing hormone; SHIM = Sexual Health Inventory for Men.